Erica Fisk, MD
Foot and Ankle Surgery · Fishers, INNPI 1538480082
Payments from drug & device makers
Across 81 payments — averaging $112.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Paragon 28, Inc.$2K
- Evolution Surgical, Inc$1K
- Stryker$1K
- Crossroads Orthopedics, LLC$1K
- Johnson & Johnson$241
- plus $509 from 10 others
What the payments were for
- Travel & lodging$4,22646%
- Food & beverage$3,63740%
- Education$1,28714%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 18 | $2,462 |
| Paragon 28, Inc. | 13 | $2,135 |
| Evolution Surgical, Inc | 5 | $1,419 |
| Stryker(2 entities) | 28 | $1,269 |
| Crossroads Orthopedics, LLC | 3 | $1,115 |
| Johnson & Johnson | 2 | $241 |
| Zimmer Biomet | 1 | $134 |
| Osiris Therapeutics Inc. | 1 | $123 |
| Smith+Nephew | 3 | $57 |
| Medline Industries LP | 1 | $49 |
| DJO, LLC | 1 | $47 |
| Vertex | 1 | $30 |
| MML US, Inc. | 1 | $26 |
| Fidia Pharma USA Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Dynasplint Systems Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product Portfolio$1,481
- NA$363
- INFINITY ADAPTIS$160
- EASYFUSE$157
- AccuFill$134
- APEX 3D$133
- Stravix$123
- Grafix$123
- GrafixPL$123
- VARIAX$120
- HAMMERLOCK$119
- Portfolio$116
How this compares
$9,149 in reported general payments places this provider in the 70th percentile of 212 foot and ankle surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 63 | $631 |
| Celecoxib | 38 | $503 |
| Tramadol Hcl | 88 | $448 |
| Oxycodone Hcl | 67 | $388 |
| Meloxicam | 111 | $291 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $199 |
| Doxycycline Hyclate | 15 | $157 |
| Methylprednisolone | 17 | $127 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Fishers
- Steven HerbstMuncie$1.6M
- Douglas BlacklidgeKokomo$689K
- Patrick DeheerIndianapolis$493K
- Scott NevilleMooresville$353K
- Travis MontgomeryWestfield$345K
- Robert Clemency IiiSchererville$215K
- William AdamsGreenfield$178K
- Christopher WintersCarmel$158K
- Steven DouthettFort Wayne$153K
- Brian ElliottShelbyville$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.